Summary: T2D-CATCH Federal Project Grant Award

Albert Einstein College of Medicine received a $827,240 Project Grant award effective June 1, 2026, through March 31, 2031, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports the T2D-CATCH (Type 2 Diabetes—Collaboration Around Technology Using Community Health Workers) initiative, which delivers research and implementation services addressing barriers to continuous glucose monitoring (CGM) therapy adoption in primary care settings. The project conducts a 12-month randomized controlled trial enrolling 500 participants with high-risk type 2 diabetes (HbA1c ≥9%) and at least one health-related social need, comparing an enhanced community health worker intervention model against usual care.

The core services delivered through this award include designing and testing an evidence-based community health worker model that simultaneously addresses health-related social needs and facilitates navigation to CGM therapy for underserved populations. The project generates implementation science outcomes and clinical effectiveness data (including HbA1c and quality-of-life measures) to evaluate the T2D-CATCH intervention's potential for scalability and sustainability across primary care systems. Research activities are performed at the awardee facility in the Bronx, New York, leveraging recent Medicaid coverage expansions for CGM to enhance real-world feasibility and long-term sustainability of the intervention model.